318 institutions reported holding $4.06B of DENALI THERAPEUTICS INC (DNLI) in SEC 13F filings for 2026-06-30. Largest institutional holders: T. Rowe Price Investment Management, Inc. ($416.1M), BlackRock, Inc. ($360.8M), VANGUARD GROUP INC ($359.7M), BAILLIE GIFFORD & CO ($307.6M), STATE STREET CORP ($181.3M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30